
Chemical and Pharmaceutical Bulletin p. 1468 - 1473 (1998)
Update date:2022-07-30
Topics:
Suzuki, Takeshi
Nagaoka, Hitoshi
Kondo, Yutaka
Takahashi, Takumi
Takeuchi, Makoto
Hara, Hiromu
Saito, Munetoshi
Yamada, Toshimitsu
Tomioka, Kenichi
Hamada, Mamoru
Mase, Toshiyasu
Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)- 4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461), which is a potent platelet-activating factor (PAF) antagonist, to other rings was performed, and PAF antagonistic activitie
View MoreBeijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd.
website:http://www.shydtec.com
Contact:86-21-57721279
Address:Science and Technology Park, Songjiang District, Shanghai, China
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
SHANDONG QINGYUNCHANGXIN CHEMICAL SCIENCE-TECH CO.,LTD
Contact:86-21-60560171
Address:1689Donghuan Rade,Qingyun County, Dezhou City, Shandong,China
Nanjing Hemings New Material Tech Co.,Ltd.
Contact:+86-25-86606739
Address:NO.186 Jiangdong Mid Road,Nanjing China
Doi:10.1021/jo000210u
(2000)Doi:10.1021/ol000072v
(2000)Doi:10.1139/v70-348
(1970)Doi:10.1021/ja001958x
(2000)Doi:10.1002/1099-0682(200007)2000:7<1523::AID-EJIC1523>3.0.CO;2-2
(2000)Doi:10.1016/S0040-4039(01)87376-7
(1973)